SciTransfer
Organization

STERIPACK MEDICAL POLAND SP ZOO

Polish medical device packaging SME manufacturing sterile healthcare products for GI diagnostics, enteral nutrition, and operating room safety.

Technology SMEhealthPLSMENo active H2020 projectsThin data (2/5)
H2020 projects
3
As coordinator
0
Total EC funding
€1.6M
Unique partners
12
What they do

Their core work

Steripack Medical Poland is a Polish SME specializing in sterile medical packaging and medical device manufacturing, with a focus on bringing healthcare products from prototype to market. They contribute manufacturing and packaging expertise to EU innovation projects targeting medical devices for gastrointestinal diagnostics, enteral nutrition delivery, and operating room safety. Their consistent participation in Innovation Actions (IA) signals a company positioned at the commercialization end of the R&D pipeline — turning research prototypes into manufactured, market-ready medical products.

Core expertise

What they specialise in

Sterile medical device packaging and manufacturingprimary
3 projects

Core business capability underpinning all three H2020 projects (PillSense, PORSAV, Mobility), providing production and packaging for medical devices.

Enteral feeding and medical nutrition devicesprimary
1 project

The Mobility project (EUR 790K, their largest) focuses on a next-generation wearable tube feeding system for patient-centric nutrition delivery.

Operating room safety and aerosol controlsecondary
1 project

PORSAV project addresses viral aerosol containment using vacuum technology and schlieren imaging, a direct COVID-19 response for healthcare worker protection.

Gastrointestinal diagnostic devicessecondary
1 project

PillSense project targets a real-time diagnostic and monitoring device for the upper gastrointestinal tract.

Evolution & trajectory

How they've shifted over time

Early focus
GI diagnostic devices
Recent focus
Wearable medical devices and OR safety

All three of Steripack Medical Poland's H2020 projects were launched within a narrow 2019–2020 window, making a long-term evolution analysis difficult. However, a clear pattern emerges: the company entered H2020 with GI diagnostics (PillSense, 2019), then expanded into operating room safety driven by the COVID-19 pandemic (PORSAV, 2020) and wearable nutrition technology (Mobility, 2020). This suggests a company rapidly diversifying its medical device portfolio while maintaining its core sterile manufacturing capability.

Moving toward patient-centric wearable medical devices and infection control — two growth areas in post-pandemic healthcare where manufacturing partners are in high demand.

Collaboration profile

How they like to work

Role: specialist_contributorReach: European4 countries collaborated

Steripack Medical Poland operates exclusively as a participant, never as coordinator, which is typical for a manufacturing SME that provides production capability to innovation consortia led by others. With 12 unique partners across 4 countries in just 3 projects, they work in moderately sized consortia and do not appear locked into repeat partnerships. This makes them an accessible partner — they bring manufacturing capacity without competing for project leadership.

Collaborates with 12 distinct partners across 4 European countries, indicating a focused but growing network within the medical device innovation ecosystem. Their connections span clinical, technical, and commercial partners involved in healthcare product development.

Why partner with them

What sets them apart

As a sterile medical packaging and device manufacturing SME in Poland, Steripack fills a specific gap in EU innovation consortia: the partner who can take a medical prototype and turn it into a manufactured, packaged, market-ready product. Their participation in three distinct medical device domains (diagnostics, nutrition, infection control) demonstrates manufacturing flexibility. For consortium builders, they offer production capability at competitive Central European costs without the overhead of engaging a large contract manufacturer.

Notable projects

Highlights from their portfolio

  • Mobility
    Largest funding (EUR 790K) and longest duration (2020-2023), targeting the commercially promising wearable enteral feeding market.
  • PORSAV
    Direct COVID-19 response project using schlieren imaging and vacuum technology to protect healthcare workers from viral aerosols in operating rooms.
Cross-sector capabilities
Medical device manufacturingSterile packaging for food and pharmaInfection control and cleanroom technologyWearable device production
Analysis note: Profile based on only 3 H2020 projects, all launched within a 2-year window (2019-2020). The company name and project roles strongly suggest sterile packaging and medical device manufacturing, but with limited project data and no coordinator roles, the depth of their specific technical contributions remains partially inferred. The website domain (valcon.pl) differs from the company name, suggesting possible corporate restructuring or group affiliation that could not be verified from project data alone.